_id
6915f06fbc934aba376b1ff2
Ticker
RNXT
Name
RenovoRx Inc
Exchange
NASDAQ
Address
2570 West El Camino Real, Mountain View, CA, United States, 94040
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://renovorx.com
Description
RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. RenovoRx, Inc. was founded in 2009 and is headquartered in Mountain View, California.
Last Close
0.9929
Volume
233016
Current Price
0.96
Change
-3.313526034847421
Last Updated
2025-12-03T13:04:07.212Z
Image
data:image/webp;base64,UklGRvQFAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSIwDAAABoITtnyFJ+uIfkWvbPo1nqte2bdu2bdu2bdu2bXu3sjIif4fMyuqa8xwiYgIYJ6Dr3sh1HysaWjDXpaEL5vqWdTfAXCVk3Q2cd/2Z4LEXnqt/4rxlpsY5HEOeef652ucfPWbpCeiLY6J/Vaq+1Hd7BueMgajuSe8tb+b68peKsktMunICPGPyVJR1Skln4Pvyr/TGqWeeceZpV3yo2NaNZrRiqcePOuGIow675HMVhU7G+nQtgGPKg5IK7QetGLU3HhxTn6aUtDzWn5tcCCFkxm6K+ngW5o1JhzJeCCEzTlauJ8EBNnjUeuNJtbUX88WkgzEAz1Rvq9DyjAfgalwluEHAs5GirqfVhMAZamtfDr/1yjs3xADPfnddec/WuEEwBqL0KmMaeTZS0kUsUUr/j8bwrKxS/86PHwTHqEJ6rafNFHUZHK+/9dyEGJO+p1xb4RkEz1qKuoFWo8D+6ugo3IQv6H/tx3icpVyPUt/LeFymtg5i3ibOeFK5NmQ8lstL5QuxQhn17TxYD2ZmPrDYH9JfLeaLSYcSzMxnbKeoD6bHPEeorUene0cd7Yun0Y1UHYt8p1xXQitG7Y8Bjo2jOjqRgGOqV1XokzzpFhzNbh850BoYvcoR/6jQV7NWSl02bKA1MGr1K/9RrscmBDAWSCoV9cdIfA9FpyiKopSSvm0RaEWpLKqlUtQT02AAxklKqdS2eJqVqo+Fnh6CdzVdi6grpsRRdUz9jgo9bTSsUV5KpX4roi4mYDWp3W63859ioZ0J1HqWLZT01zCslwcXXWKJJZYa9oTUGY1Vki4cueD8888/4kvp2ylxFceU7yqWUU9luB6uB/CsoY4ux1ei9sWDsZ862g9f8ZyposxToX0JPdyE9z4YTyr90yLQikmHknmfMd370vvTYeBZMUZ9uOF/0v+jsV6qxuoqdAm+5mAM8OyqXHvjcUz6nqI24zTlesrMDQLYEyrbI2gEk3wgfTUFznOWcl2Hm/AltbU/vtufUdfXedbQf7oYxrRzHVjn2Un/aR/GY6n0v76cg8CynRT/G4Lr8q90R52DJ5U6y7JgjDqszjHV29JnczPHV0raDI/nCOV6dRIc1fGvveXuveswlr3jxvv2Zu6bbrp/7To8G95z/f3rsv4919x1UnDgmPjUu69/eH58zVjuqDqaZ1kWGliWZR6XZZk18FmWGZZlWaA+ZFnmuo3bEVZQOCBCAgAAMAwAnQEqQABAAD61TJ5KpyQioawYDMjgFolsAM30OYwi5iFjtjfEz6gH+730D0AOk5s/y06dWEL1eL5nyAHEm9i7cAZvuJbRoEILkxOw+eKLC1z35XjmRghKqpZcUIL24UPmDdkOdLfEAAD+/PhADTq7TVc9ueit4f62xmBm11D1k2R0Xs9TlvPqWXfd9DzLz//wa1DfzK5GLpv6BnpVfOYMe5N7cpfE56z0vttLxsWqaYsAx8xheOZXTCEZxp8KAPTHaCBIuJhkxZKJFHKXcshqUS77VHP/Eo7Hfs3+ZLXzCG1n8S7OIjUsdsxJGj3lRm5njaIsWCVigF5zOLzBiGNhrHp6WezK+22nk2udXJb8HEcplLeQ53eauFc9lXUn160bhXcrzf6pbb5dQBuR47ET622i7eN61IHppCSR15BVM+0f2a56Vt99uDZFGhaUxJxY92ftNW+ID9kv/hdt6EMp+64D67S3U2MaFmO5Zl/s/C3E4RJ0niK+X/Pm72xhpA9yOJ40NufbqJQoCQEBQn1JojVakvIMaufxcLg1I6ttSDRDygACCAQBrSwtS5Y2VKYilcrQatwaYeFYftO61YsE4kdzOagbkPEO/LQ5/zsUB/diAcG1Tk5EurJaV09hdt5/J7en5D27jPBUAMc4Gi2ehE9cPMHzNXgKTHZyTp6Acqsnt10iOjK3l2/NAGgbfySVKk+bg/nf50Vpo2DptCE0Ev+hF0vCZ95eOHLWSz1OY1Y3L+ow8PP6fctNKRJIAAA=
Ipo Date
2021-08-26T00:00:00.000Z
Market Cap
30980174
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.819
Sentiment Sources
7
Rating
4.5
Target Price
5.5625
Strong Buy
2
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
266000
Cost Of Revenue
53000
Gross Profit
213000
Operating Expenses
3413000
Operating Income
-3200000
Interest Expense
-
Pretax Income
-2912000
Net Income
-2912000
Eps
-0.07946236722867189
Dividends Per Share
-
Shares Outstanding
36649916
Income Tax Expense
-
EBITDA
-2911000
Operating Margin
-1203.0075187969924
Total Other Income Expense Net
288000
Cash
10044000
Short Term Investments
-
Receivables
169000
Inventories
272000
Total Current Assets
10980000
Property Plant Equipment
226000
Total Assets
11206000
Payables
869000
Short Term Debt
102000
Long Term Debt
-
Total Liabilities
3128000
Equity
8078000
Depreciation
-1000
Change In Working Capital
446000
Cash From Operations
-2270000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
0
Net Change In Cash
-2270000
PE
-
PB
4.355091220599158
ROE
-36.04852686308492
ROA
-25.986078886310903
FCF
-2270000
Fcf Percent
-8.533834586466165
Piotroski FScore
1
Health Score
30
Deep Value Investing Score
4
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
2
Net Net Investing Score
3
Quality Investing Score
2.5
Value Investing Score
3.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
266000
Quarters > 0 > income Statement > cost Of Revenue
53000
Quarters > 0 > income Statement > gross Profit
213000
Quarters > 0 > income Statement > operating Expenses
3413000
Quarters > 0 > income Statement > operating Income
-3200000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-2912000
Quarters > 0 > income Statement > net Income
-2912000
Quarters > 0 > income Statement > eps
-0.07946236722867189
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
36646278
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-2911000
Quarters > 0 > income Statement > operating Margin
-1203.0075187969924
Quarters > 0 > income Statement > total Other Income Expense Net
288000
Quarters > 0 > balance Sheet > cash
10044000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
169000
Quarters > 0 > balance Sheet > inventories
272000
Quarters > 0 > balance Sheet > total Current Assets
10980000
Quarters > 0 > balance Sheet > property Plant Equipment
226000
Quarters > 0 > balance Sheet > total Assets
11206000
Quarters > 0 > balance Sheet > payables
869000
Quarters > 0 > balance Sheet > short Term Debt
102000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
3128000
Quarters > 0 > balance Sheet > equity
8078000
Quarters > 0 > cash Flow > net Income
-2912000
Quarters > 0 > cash Flow > depreciation
-1000
Quarters > 0 > cash Flow > change In Working Capital
446000
Quarters > 0 > cash Flow > cash From Operations
-2270000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-2270000
Quarters > 0 > ratios > PE
-0.07946236722867189
Quarters > 0 > ratios > PB
4.355091220599158
Quarters > 0 > ratios > ROE
-36.04852686308492
Quarters > 0 > ratios > ROA
-25.986078886310903
Quarters > 0 > ratios > FCF
-2270000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-8.533834586466165
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
422000
Quarters > 1 > income Statement > cost Of Revenue
152000
Quarters > 1 > income Statement > gross Profit
270000
Quarters > 1 > income Statement > operating Expenses
2948000
Quarters > 1 > income Statement > operating Income
-2678000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-2895000
Quarters > 1 > income Statement > net Income
-2895000
Quarters > 1 > income Statement > eps
-0.07914903550133615
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
36576567
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-2677000
Quarters > 1 > income Statement > operating Margin
-634.5971563981043
Quarters > 1 > income Statement > total Other Income Expense Net
-217000
Quarters > 1 > balance Sheet > cash
12314000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
363000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
13395000
Quarters > 1 > balance Sheet > property Plant Equipment
248000
Quarters > 1 > balance Sheet > total Assets
13643000
Quarters > 1 > balance Sheet > payables
671000
Quarters > 1 > balance Sheet > short Term Debt
99000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
3002000
Quarters > 1 > balance Sheet > equity
10641000
Quarters > 1 > cash Flow > net Income
-2895000
Quarters > 1 > cash Flow > depreciation
1000
Quarters > 1 > cash Flow > change In Working Capital
-123000
Quarters > 1 > cash Flow > cash From Operations
-2302000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
34000
Quarters > 1 > cash Flow > net Change In Cash
-2268000
Quarters > 1 > ratios > PE
-0.07914903550133615
Quarters > 1 > ratios > PB
3.2998312489427684
Quarters > 1 > ratios > ROE
-27.206089653228084
Quarters > 1 > ratios > ROA
-21.21967309242835
Quarters > 1 > ratios > FCF
-2302000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-5.454976303317536
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
197000
Quarters > 2 > income Statement > cost Of Revenue
94000
Quarters > 2 > income Statement > gross Profit
103000
Quarters > 2 > income Statement > operating Expenses
3213000
Quarters > 2 > income Statement > operating Income
-3110000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-2420000
Quarters > 2 > income Statement > net Income
-2420000
Quarters > 2 > income Statement > eps
-0.07708015775823891
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
31395888
Quarters > 2 > income Statement > income Tax Expense
2476000
Quarters > 2 > income Statement > EBITDA
-2419000
Quarters > 2 > income Statement > operating Margin
-1578.6802030456852
Quarters > 2 > income Statement > total Other Income Expense Net
690000
Quarters > 2 > balance Sheet > cash
14582000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
242000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
15745000
Quarters > 2 > balance Sheet > property Plant Equipment
269000
Quarters > 2 > balance Sheet > total Assets
16014000
Quarters > 2 > balance Sheet > payables
967000
Quarters > 2 > balance Sheet > short Term Debt
97000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2857000
Quarters > 2 > balance Sheet > equity
13157000
Quarters > 2 > cash Flow > net Income
-2420000
Quarters > 2 > cash Flow > depreciation
1000
Quarters > 2 > cash Flow > change In Working Capital
-688000
Quarters > 2 > cash Flow > cash From Operations
-3381000
Quarters > 2 > cash Flow > capital Expenditures
2000
Quarters > 2 > cash Flow > cash From Investing
-2000
Quarters > 2 > cash Flow > cash From Financing
10811000
Quarters > 2 > cash Flow > net Change In Cash
7428000
Quarters > 2 > ratios > PE
-0.07708015775823891
Quarters > 2 > ratios > PB
2.2907997628638745
Quarters > 2 > ratios > ROE
-18.39325074105039
Quarters > 2 > ratios > ROA
-15.111777194954415
Quarters > 2 > ratios > FCF
-3383000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-17.17258883248731
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
43000
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
2675000
Quarters > 3 > income Statement > operating Income
-2632000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-2878000
Quarters > 3 > income Statement > net Income
-2878000
Quarters > 3 > income Statement > eps
-0.11974367696800689
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
24034672
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-6120.930232558139
Quarters > 3 > income Statement > total Other Income Expense Net
-331000
Quarters > 3 > balance Sheet > cash
7154000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
43000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
7828000
Quarters > 3 > balance Sheet > property Plant Equipment
290000
Quarters > 3 > balance Sheet > total Assets
8118000
Quarters > 3 > balance Sheet > payables
586000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
3640000
Quarters > 3 > balance Sheet > equity
4478000
Quarters > 3 > cash Flow > net Income
-2878000
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
-142000
Quarters > 3 > cash Flow > cash From Operations
-2430000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
33000
Quarters > 3 > cash Flow > net Change In Cash
-2409000
Quarters > 3 > ratios > PE
-0.11974367696800689
Quarters > 3 > ratios > PB
5.152587119249665
Quarters > 3 > ratios > ROE
-64.26976328718177
Quarters > 3 > ratios > ROA
-35.45208179354521
Quarters > 3 > ratios > FCF
-2430000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-56.51162790697674
Quarters > 3 > health Score
26
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
43000
Annuals > 0 > income Statement > cost Of Revenue
0
Annuals > 0 > income Statement > gross Profit
43000
Annuals > 0 > income Statement > operating Expenses
11013000
Annuals > 0 > income Statement > operating Income
-10970000
Annuals > 0 > income Statement > interest Expense
384000
Annuals > 0 > income Statement > pretax Income
-8814000
Annuals > 0 > income Statement > net Income
-8814000
Annuals > 0 > income Statement > eps
-0.3733803610148371
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
23605955
Annuals > 0 > income Statement > income Tax Expense
-8814000
Annuals > 0 > income Statement > EBITDA
-10970000
Annuals > 0 > income Statement > operating Margin
-25511.627906976744
Annuals > 0 > income Statement > total Other Income Expense Net
2156000
Annuals > 0 > balance Sheet > cash
7154000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
43000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
7828000
Annuals > 0 > balance Sheet > property Plant Equipment
290000
Annuals > 0 > balance Sheet > total Assets
8118000
Annuals > 0 > balance Sheet > payables
586000
Annuals > 0 > balance Sheet > short Term Debt
66000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
3640000
Annuals > 0 > balance Sheet > equity
4478000
Annuals > 0 > cash Flow > net Income
-8814000
Annuals > 0 > cash Flow > depreciation
-
Annuals > 0 > cash Flow > change In Working Capital
280000
Annuals > 0 > cash Flow > cash From Operations
-9125000
Annuals > 0 > cash Flow > capital Expenditures
12000
Annuals > 0 > cash Flow > cash From Investing
-12000
Annuals > 0 > cash Flow > cash From Financing
15118000
Annuals > 0 > cash Flow > net Change In Cash
5981000
Annuals > 0 > ratios > PE
-0.3733803610148371
Annuals > 0 > ratios > PB
4.456032550580616
Annuals > 0 > ratios > ROE
-196.82894149173737
Annuals > 0 > ratios > ROA
-108.57354028085734
Annuals > 0 > ratios > FCF
-9137000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-212.48837209302326
Annuals > 0 > health Score
26
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
0
Annuals > 1 > income Statement > gross Profit
0
Annuals > 1 > income Statement > operating Expenses
11396000
Annuals > 1 > income Statement > operating Income
-11396000
Annuals > 1 > income Statement > interest Expense
108000
Annuals > 1 > income Statement > pretax Income
-10232000
Annuals > 1 > income Statement > net Income
-10232000
Annuals > 1 > income Statement > eps
-0.4971495044976191
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
20581334
Annuals > 1 > income Statement > income Tax Expense
-6
Annuals > 1 > income Statement > EBITDA
-11390000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
1164000
Annuals > 1 > balance Sheet > cash
1173000
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
0
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
1466000
Annuals > 1 > balance Sheet > property Plant Equipment
0
Annuals > 1 > balance Sheet > total Assets
1466000
Annuals > 1 > balance Sheet > payables
561000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
4466000
Annuals > 1 > balance Sheet > equity
-3000000
Annuals > 1 > cash Flow > net Income
-10232000
Annuals > 1 > cash Flow > depreciation
0
Annuals > 1 > cash Flow > change In Working Capital
605000
Annuals > 1 > cash Flow > cash From Operations
-10258000
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
2032000
Annuals > 1 > cash Flow > cash From Financing
5008000
Annuals > 1 > cash Flow > net Change In Cash
-3218000
Annuals > 1 > ratios > PE
-0.4971495044976191
Annuals > 1 > ratios > PB
-5.799133876733333
Annuals > 1 > ratios > ROE
341.06666666666666
Annuals > 1 > ratios > ROA
-697.9536152796726
Annuals > 1 > ratios > FCF
-10258000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
6000
Annuals > 2 > income Statement > gross Profit
-6000
Annuals > 2 > income Statement > operating Expenses
9950000
Annuals > 2 > income Statement > operating Income
-9950000
Annuals > 2 > income Statement > interest Expense
57000
Annuals > 2 > income Statement > pretax Income
-9889000
Annuals > 2 > income Statement > net Income
-9771000
Annuals > 2 > income Statement > eps
-0.5397313175409861
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
18103452
Annuals > 2 > income Statement > income Tax Expense
-118000
Annuals > 2 > income Statement > EBITDA
-9944000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
61000
Annuals > 2 > balance Sheet > cash
4391000
Annuals > 2 > balance Sheet > short Term Investments
2049000
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
7265000
Annuals > 2 > balance Sheet > property Plant Equipment
0
Annuals > 2 > balance Sheet > total Assets
7265000
Annuals > 2 > balance Sheet > payables
534000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1102000
Annuals > 2 > balance Sheet > equity
6163000
Annuals > 2 > cash Flow > net Income
-9889000
Annuals > 2 > cash Flow > depreciation
6000
Annuals > 2 > cash Flow > change In Working Capital
428000
Annuals > 2 > cash Flow > cash From Operations
-8811000
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-2032000
Annuals > 2 > cash Flow > cash From Financing
42000
Annuals > 2 > cash Flow > net Change In Cash
-10801000
Annuals > 2 > ratios > PE
-0.5397313175409861
Annuals > 2 > ratios > PB
2.4830193048190816
Annuals > 2 > ratios > ROE
-158.5429174103521
Annuals > 2 > ratios > ROA
-134.49415003441158
Annuals > 2 > ratios > FCF
-8811000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
9000
Annuals > 3 > income Statement > gross Profit
-9000
Annuals > 3 > income Statement > operating Expenses
5671000
Annuals > 3 > income Statement > operating Income
-5671000
Annuals > 3 > income Statement > interest Expense
834000
Annuals > 3 > income Statement > pretax Income
-6324000
Annuals > 3 > income Statement > net Income
-6324000
Annuals > 3 > income Statement > eps
-0.3539292470586207
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
17867978
Annuals > 3 > income Statement > income Tax Expense
772000
Annuals > 3 > income Statement > EBITDA
-5481000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-653000
Annuals > 3 > balance Sheet > cash
15192000
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
16281000
Annuals > 3 > balance Sheet > property Plant Equipment
6000
Annuals > 3 > balance Sheet > total Assets
16287000
Annuals > 3 > balance Sheet > payables
525000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
938000
Annuals > 3 > balance Sheet > equity
15349000
Annuals > 3 > cash Flow > net Income
-6324000
Annuals > 3 > cash Flow > depreciation
9000
Annuals > 3 > cash Flow > change In Working Capital
-265000
Annuals > 3 > cash Flow > cash From Operations
-5916000
Annuals > 3 > cash Flow > capital Expenditures
15000
Annuals > 3 > cash Flow > cash From Investing
-15000
Annuals > 3 > cash Flow > cash From Financing
19328000
Annuals > 3 > cash Flow > net Change In Cash
13397000
Annuals > 3 > ratios > PE
-0.3539292470586207
Annuals > 3 > ratios > PB
0.984025135409473
Annuals > 3 > ratios > ROE
-41.201381197472145
Annuals > 3 > ratios > ROA
-38.82851353840486
Annuals > 3 > ratios > FCF
-5931000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.07946236722867189
Valuation > metrics > PB
4.355091220599158
Valuation > final Score
36.44908779400842
Valuation > verdict
45.2% Overvalued
Profitability > metrics > ROE
-36.04852686308492
Profitability > metrics > ROA
-26.520947176684885
Profitability > metrics > Net Margin
-10.947368421052632
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.3872245605347858
Risk > metrics > Interest Coverage
-3200
Risk > final Score
-12740
Risk > verdict
High
Liquidity > metrics > Current Ratio
11.307929969104016
Liquidity > metrics > Quick Ratio
11.027806385169928
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
47.00168751057232
Prev Valuations > 1
80
Prev Valuations > 2
28.47412880750335
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
11
Prev Risks > 1
-12380
Prev Risks > 2
16
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-13T01:18:32.660Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-17
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.08
Earnings History > 0 > eps Estimate
-0.08
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
0
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-14
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.08
Earnings History > 1 > eps Estimate
-0.09
Earnings History > 1 > eps Difference
0.01
Earnings History > 1 > surprise Percent
11.1111
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-04-01
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.11
Earnings History > 2 > eps Estimate
-0.1
Earnings History > 2 > eps Difference
-0.01
Earnings History > 2 > surprise Percent
-10
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2024-12-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.12
Earnings History > 3 > eps Estimate
-0.125
Earnings History > 3 > eps Difference
0.005
Earnings History > 3 > surprise Percent
4
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-14
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.1
Earnings History > 4 > eps Estimate
-0.1167
Earnings History > 4 > eps Difference
0.0167
Earnings History > 4 > surprise Percent
14.3102
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-15
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.1
Earnings History > 5 > eps Estimate
-0.1
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
0
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-10
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.07
Earnings History > 6 > eps Estimate
-0.14
Earnings History > 6 > eps Difference
0.07
Earnings History > 6 > surprise Percent
50
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-19
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.31
Earnings History > 7 > eps Estimate
-0.3
Earnings History > 7 > eps Difference
-0.01
Earnings History > 7 > surprise Percent
-3.3333
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-13
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.13
Earnings History > 8 > eps Estimate
-0.3
Earnings History > 8 > eps Difference
0.17
Earnings History > 8 > surprise Percent
56.6667
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-16
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.31
Earnings History > 9 > eps Estimate
-0.25
Earnings History > 9 > eps Difference
-0.06
Earnings History > 9 > surprise Percent
-24
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-12
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.36
Earnings History > 10 > eps Estimate
-0.25
Earnings History > 10 > eps Difference
-0.11
Earnings History > 10 > surprise Percent
-44
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-02
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.23
Earnings History > 11 > eps Estimate
-0.26
Earnings History > 11 > eps Difference
0.03
Earnings History > 11 > surprise Percent
11.5385
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-14
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.24
Earnings History > 12 > eps Estimate
-0.29
Earnings History > 12 > eps Difference
0.05
Earnings History > 12 > surprise Percent
17.2414
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-12
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.29
Earnings History > 13 > eps Estimate
-0.28
Earnings History > 13 > eps Difference
-0.01
Earnings History > 13 > surprise Percent
-3.5714
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-13
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.33
Earnings History > 14 > eps Estimate
-0.21
Earnings History > 14 > eps Difference
-0.12
Earnings History > 14 > surprise Percent
-57.1429
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-30
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.12
Earnings History > 15 > eps Estimate
-0.16
Earnings History > 15 > eps Difference
0.04
Earnings History > 15 > surprise Percent
25
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-15
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.27
Earnings History > 16 > eps Estimate
-0.21
Earnings History > 16 > eps Difference
-0.06
Earnings History > 16 > surprise Percent
-28.5714
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-27
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.48
Earnings History > 17 > eps Estimate
-0.58
Earnings History > 17 > eps Difference
0.1
Earnings History > 17 > surprise Percent
17.2414
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-06-30
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.5733
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.5733
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-31
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.512
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.512
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-03-31
Earnings History > 20 > report Date
2020-06-30
Earnings History > 20 > date
2020-03-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.3485
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.3485
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2019-12-31
Earnings History > 21 > report Date
2020-03-31
Earnings History > 21 > date
2019-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.4788
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.4788
Earnings History > 21 > surprise Percent
-
RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. RenovoRx, Inc. was founded in 2009 and is headquartered in Mountain View, California.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ARenovoRx (Nasdaq: RNXT) to Present TIGeR-PaC PK/PD Data at ASCO GI Symposium 2026 - Stock Titan
12/11/2025
RenovoRx (Nasdaq: RNXT) to Present TIGeR-PaC PK/PD Data at ASCO GI Symposium 2026 Stock Titan
Read more →Agah Ramtin, RenovoRx chief medical officer, buys $9,600 in RNXT Investing.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$5.5625
Analyst Picks
Strong Buy
2
Buy
2
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 29.35% of the total shares of RenovoRx Inc
1.
AIGH Capital Management, LLC(9.4616%)
since
2025/06/30
2.
Awm Investment Company Inc(5.1035%)
since
2025/06/30
3.
Vanguard Group Inc(4.5395%)
since
2025/06/30
4.
Vanguard Total Stock Mkt Idx Inv(2.8221%)
since
2025/07/31
5.
Bleichroeder LP(1.3644%)
since
2025/06/30
6.
Geode Capital Management, LLC(0.9649%)
since
2025/06/30
7.
Vanguard Institutional Extnd Mkt Idx Tr(0.8397%)
since
2025/07/31
8.
Renaissance Technologies Corp(0.6871%)
since
2025/06/30
9.
Fidelity Extended Market Index(0.5034%)
since
2025/07/31
10.
Vanguard Balanced Index Inv(0.4763%)
since
2025/07/31
11.
Watch Point Trust Co(0.2651%)
since
2025/06/30
12.
Corsair Capital Management LLC(0.2603%)
since
2025/06/30
13.
Chicago Partners Investment Group LLC(0.252%)
since
2025/06/30
14.
Fidelity Total Market Index(0.2143%)
since
2025/07/31
15.
Northwestern Mutual Wealth Management Co(0.2036%)
since
2025/06/30
16.
Charles Schwab Investment Management Inc(0.1343%)
since
2025/06/30
17.
Schwab Total Stock Market Index(0.1343%)
since
2025/07/31
18.
Fidelity Series Total Market Index(0.128%)
since
2025/07/31
19.
HighTower Advisors, LLC(0.1092%)
since
2025/06/30
20.
Kestra Advisory Services, LLC(0.0969%)
since
2025/06/30
21.
UBS Group AG(0.0819%)
since
2025/06/30
22.
Spartan Extended Market Index Pool F(0.0779%)
since
2025/07/31
23.
Northern Trust Corp(0.0731%)
since
2025/06/30
24.
State Street Corp(0.0714%)
since
2025/06/30
25.
NT Ext Equity Mkt Idx Fd - L(0.0708%)
since
2025/06/30
26.
Northern Trust Extended Eq Market Idx(0.0708%)
since
2025/06/30
27.
TWO SIGMA SECURITIES, LLC(0.0596%)
since
2025/06/30
28.
Spartan Total Market Index Pool G(0.0592%)
since
2025/07/31
29.
HRT FINANCIAL LLC(0.0563%)
since
2025/06/30
30.
ADAR1 Capital Management LLC(0.0543%)
since
2025/06/30
31.
Affinity Capital Advisors, LLC(0.0362%)
since
2025/06/30
32.
State St US Extended Mkt Indx NL Cl C(0.0221%)
since
2025/08/31
33.
Fidelity Nasdaq Composite Index(0.0213%)
since
2025/07/31
34.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.02%)
since
2025/06/30
35.
SSgA U.S. Total Market Index Strategy(0.0093%)
since
2025/03/31
36.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0032%)
since
2024/12/31
37.
Northern Trust Wilshire 5000(0.0023%)
since
2025/06/30
38.
Fidelity U.S. Equity Index Ins Trust(0.0002%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.08
EPS Estimate
-0.08
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.